Join

Compare · ALMR vs BIO

ALMR vs BIO

Side-by-side comparison of Alamar Biosciences Inc. (ALMR) and Bio-Rad Laboratories Inc. (BIO): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both ALMR and BIO operate in Biotechnology: Laboratory Analytical Instruments (Industrials), so they compete in similar markets.
  • BIO is the larger of the two at $8.16B, about 5.6x ALMR ($1.45B).
  • Over the past year, ALMR is down 5.7% and BIO is up 37.2% - BIO leads by 42.8 points.
  • ALMR has been more active in the news (6 items in the past 4 weeks vs 1 for BIO).
  • BIO has more recent analyst coverage (12 ratings vs 5 for ALMR).
PerformanceALMR-5.65%BIO+1.90%
2026-04-17+0.00%2026-06-03
MetricALMRBIO
Company
Alamar Biosciences Inc.
Bio-Rad Laboratories Inc.
Price
$20.94+0.53%
$304.75-0.42%
Market cap
$1.45B
$8.16B
1M return
-12.20%
+18.20%
1Y return
-5.65%
+37.16%
Industry
Biotechnology: Laboratory Analytical Instruments
Biotechnology: Laboratory Analytical Instruments
Exchange
NASDAQ
NYSE
IPO
2026
1980
News (4w)
6
1
Recent ratings
5
12
BIO

Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, Inc. develops, manufactures, and markets life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. It operates in two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cell biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, transfusion laboratories, and insurance and forensic testing laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

Latest ALMR

Latest BIO